Mark A Russell
Overview
Explore the profile of Mark A Russell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1010
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akhbari P, Perez-Hernandez J, Russell M, Dhayal S, Leslie K, Hunter S, et al.
Diabetes
. 2025 Mar;
PMID: 40063529
HLA class I (HLA-I) molecules present intracellular antigenic peptides to CD8+ T lymphocytes during immune surveillance. In donors with type 1 diabetes, hyperexpression of HLA-I occurs in islets with residual...
2.
Lee J, Dao D, Russell M, Guffey D
Cutis
. 2025 Feb;
115(1):18-20.
PMID: 39946248
No abstract available.
3.
Leslie K, Lekka C, Richardson S, Russell M, Morgan N
Diabetes
. 2024 Jun;
73(9):1473-1485.
PMID: 38869827
Article Highlights:
4.
Salah H, Duran J, Russell M, Gru A
Am J Dermatopathol
. 2024 Apr;
46(7):433-435.
PMID: 38648032
Apocrine hidrocystomas are benign, cystic neoplastic lesions resulting from the apocrine secretory component of the sweat gland. They most commonly occur on the head and neck, with predilection to the...
5.
Russell M, Richardson S, Morgan N
Front Endocrinol (Lausanne)
. 2023 Oct;
14:1270325.
PMID: 37867531
The hyperexpression of human leukocyte antigen class I (HLA-I) molecules on pancreatic beta-cells is widely accepted as a hallmark feature of type 1 diabetes pathogenesis. This response is important clinically...
6.
Leiding J, Vogel T, Santarlas V, Mhaskar R, Smith M, Carisey A, et al.
J Allergy Clin Immunol
. 2022 Oct;
151(4):1081-1095.
PMID: 36228738
Background: In 2014, germline signal transducer and activator of transcription (STAT) 3 gain-of-function (GOF) mutations were first described to cause a novel multisystem disease of early-onset lymphoproliferation and autoimmunity. Objective:...
7.
Krogvold L, Leete P, Mynarek I, Russell M, Gerling I, Lenchik N, et al.
Front Endocrinol (Lausanne)
. 2022 Aug;
13:881997.
PMID: 35957810
Aims/hypothesis: The Diabetes Virus Detection (DiViD) study has suggested the presence of low-grade enteroviral infection in pancreatic tissue collected from six of six live adult patients newly diagnosed with type...
8.
McLaughlin C, Russell M
Ann Palliat Med
. 2022 May;
11(10):3337-3340.
PMID: 35542971
Background: Cutaneous squamous cell carcinoma (cSCC) is a common malignancy affecting the skin, and its incidence increases with age; as such, it disproportionately affects the elderly. It is especially difficult...
9.
Dhayal S, Leslie K, Baity M, Akhbari P, Richardson S, Russell M, et al.
J Mol Endocrinol
. 2022 May;
69(2):299-313.
PMID: 35521765
During the development of type 1 diabetes, interferons (IFN) are elaborated from islet-infiltrating immune cells and/or from virally infected β-cells. They act via specific receptors to increase, acutely, the phosphorylation...
10.
Guerra R, Guffey D, Russell M
Dermatol Surg
. 2021 Dec;
48(12):1337-1339.
PMID: 34923526
No abstract available.